Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

889 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A. Staessen JA, et al. Lancet. 1997 Sep 13;350(9080):757-64. doi: 10.1016/s0140-6736(97)05381-6. Lancet. 1997. PMID: 9297994 Clinical Trial.
Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.
Staessen JA, Fagard R, Thijs L, Celis H, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Fletcher AE, Babarskiene MR, Forette F, Kocemba J, Laks T, Leonetti G, Nachev C, Petrie JC, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Zanchetti A. Staessen JA, et al. Arch Intern Med. 1998 Aug 10-24;158(15):1681-91. doi: 10.1001/archinte.158.15.1681. Arch Intern Med. 1998. PMID: 9701103 Clinical Trial.
Systolic Hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress. Systolic Hypertension in Europe Investigators.
Gasowski J, Staessen JA, Celis H, Fagard RH, Thijs L, Birkenhäger WH, Bulpitt CJ, Fletcher AE, Arabidze GG, de Leeuw P, Dollery CT, Duggan J, Kawecka-Jaszcz K, Leonetti G, Nachev C, Safar M, Rodico JL, Rosenfeld J, Seux ML, Tuomilehto J, Webster J, Yodfat Y. Gasowski J, et al. Among authors: staessen ja. J Hum Hypertens. 1999 Feb;13(2):135-45. doi: 10.1038/sj.jhh.1000769. J Hum Hypertens. 1999. PMID: 10100063 Clinical Trial.
Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial.
Celis H, Thijs L, Staessen JA, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Leonetti G, Nachev C, Tuomilehto J, Fagard RH; Syst-Eur Investigators. Celis H, et al. Among authors: staessen ja. J Hum Hypertens. 2001 Sep;15(9):613-8. doi: 10.1038/sj.jhh.1001235. J Hum Hypertens. 2001. PMID: 11550107 Free article. Clinical Trial.
Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension.
Staessen JA, Thijs L, Fagard RH, Birkenhäger WH, Arabidze G, Babeanu S, Gil-Extremera B, Bulpitt CJ, Davidson C, de Leeuw PW, Efstratopoulos AD, Fletcher AE, Fogari R, Jääskivi M, Kawecka-Jaszcz K, Nachev C, Petrie JC, Seux ML, Tuomilehto J, Webster J, Yodfat Y. Staessen JA, et al. Hypertension. 1998 Sep;32(3):410-6. doi: 10.1161/01.hyp.32.3.410. Hypertension. 1998. PMID: 9740604 Clinical Trial.
889 results